Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Young and Older Folk Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: chowder who wrote (869)	3/17/2022 2:23:35 PM
From: OneDonatoOne	1 Recommendation Recommended By red cardinal Read Replies (1) \| Respond to of 24155

I like your move in D, not sure many are paying attention. D announced on March 2 the dividend will increase 6% to .67 effective March 20. D is investing as anticipated while the state of Virginia agrees. Many still have that thorn in their side and let emotions get the best of them. D is one of my largest positions.

To: chowder who wrote (869)	3/17/2022 6:44:14 PM
From: chowder	2 Recommendations Recommended By OneDonatoOne red cardinal Read Replies (1) \| Respond to of 24155

Re: Middle Age Portfolio ... Adjustments. Today I was simply adding to positions that I want to build up in size more, bringing them up to full positions. I sold the position in SPYD and with the proceeds from the sale of MMP earlier in the week, I added to the following today: AAPL .. CCI .. MS .. MSFT .. TROW. I started new positions in DG and CVS. I wanted to buy DG because in an inflationary environment, especially when prices at the gas pump are high, discretionary income gets squeezed for a majority of the population and they downsize looking for lower prices, thus the dollar stores do well in this environment. DG also announced a 31% increase in the dividend today. DG also has Wall St support with the following Buy, Hold and Sell ratings. 47-15-4 ----------------- CVS has been a turnaround story of sorts. They took on an acquisition a few years ago that blew up their balance sheet and I have been waiting for them to get their debt in order. Jefferson Research now gives CVS their highest rating of Strongest with regard to the balance sheet. CVS is still considered undervalued and when combined with the lower debt and balance sheet under control, I thought it time to buy. Analyst Ratings: 57-17-0